Novel Psychoactive Substances

Classification, Pharmacology and Toxicology
2. Auflage 2021
ISBN: 978-0-12-818788-3
Verlag: Elsevier Science

Buch, Englisch, 554 Seiten, Format (B × H): 196 mm x 239 mm, Gewicht: 1310 g

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters.

Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.

Autoren/Hrsg.

Dargan, Paul I

Wood, David M

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Neuropharmakologie, Psychopharmakologie

Inhaltsverzeichnis

I. Background 1. Legal Classification and International Systems for Monitoring Novel Psychoactive Substances 2. Availability and Supply of Novel Psychoactive Substances 3. Prevalence of Use of Novel Psychoactive Substances 4. Pharmacological Profiling of Novel Psychoactive Substances 5. Novel methods of NPS detection and data triangulation 6. Social issues in the use of novel psychoactive substances 7. General management of the patient with Novel Psychoactive Substance Toxicity 8. Addiction and treatment of Novel Psychoactive Substance dependence

II. Analytical Techniques 9. Analytical techniques for the detection of novel psychoactive substances and their metabolites

III. Individual Novel Psychoactive Substances 10. Synthetic Amphetamines including novel MDMA analogues 11. Pharmacology and Toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) Hallucinogens 12. 1-Benzylpiperazine and other Piperazine-based stimulants 13. Cathinones 14. Arylcyclohexamines 15. Synthetic cannabinoids 16. Novel opioids 17. Novel benzodiazepines 18. Tryptamines

Über Autor(innen)

Wood, David M
David Wood is a Consultant Physician and Clinical Toxicologist at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

Dargan, Paul I
Professor Dargan and Dr Wood are both expert advisors on novel psychoactive substances to expert bodies in the UK (Advisory Council on the Misuse of Drugs, ACMD), Europe (European Monitoring Centre for Drugs and Drug Addiction, EMCDDA) and Worldwide (United Nations Office on Drugs and Crime, UNODC). They run a clinical service managing patients with acute drug toxicity, and have a clinical and research interest in novel psychoactive substances. They publish widely in this field and have both been invited to give keynote lectures at International meetings on this topic.